{"id":291896,"date":"2025-11-14T21:40:11","date_gmt":"2025-11-14T21:40:11","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/291896\/"},"modified":"2025-11-14T21:40:11","modified_gmt":"2025-11-14T21:40:11","slug":"redesigned-apple-watch-blood-oxygen-feature-faces-new-itc-scrutiny","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/291896\/","title":{"rendered":"Redesigned Apple Watch Blood Oxygen feature faces new ITC scrutiny"},"content":{"rendered":"

\t\"Apple<\/p>\n

In August, Apple launched a \u201credesigned\u201d version<\/a> of the Apple Watch\u2019s Blood Oxygen feature in the United States. This came 18 months after\u00a0Apple started selling<\/a> the Apple Watch without the Blood Oxygen feature in\u00a0due to a patent dispute<\/a> with health technology company Masimo.<\/p>\n

The International Trade Commission (ITC) now says that it is holding a new proceeding to decide if this solution should also be banned due to the Masimo patent dispute.<\/p>\n

In new filings today, the ITC said it \u201chas determined to institute a combined modification and enforcement proceeding\u201d to determine whether the redesigned Apple Watch blood oxygen feature is permitted under the initial ITC import ban<\/a>. The decision was made following a complaint from Masimo.<\/p>\n

According to the ITC, conditions have changed because Apple is now selling a redesigned watch that wasn\u2019t part of the original investigation. This, in turn, justifies the revisiting and will be the \u201csole issue to be resolved\u201d in the proceeding.<\/p>\n

The review includes the question of whether Apple causes infringement by selling an Apple Watch that, once paired with an iPhone, performs the disputed features.<\/p>\n

Essentially, the ITC is evaluating not just what the Apple Watch does on its own, but whether the watch and iPhone together trigger the patented technology. <\/p>\n

Apple\u2019s new implementation<\/a> of the blood oxygen feature on Apple Watch centers around viewing the results from a test on the iPhone rather than the watch. You start a session using the Blood Oxygen feature on your Apple Watch and the sensors on your Apple Watch will then collect the necessary data.<\/p>\n

The results, however, aren\u2019t viewable on the Apple Watch itself. Instead, you can find them in the Respiratory section of the Health app on your iPhone.<\/p>\n

For its part, an Apple spokesperson disputes Masimo\u2019s complaint with the ITC and says the company is attempting to pressure the ITC to block Apple Watch users in the US from accessing key health features. The company also points out that Masimo\u2019s initial ITC complaint was based on a Masimo Watch that didn\u2019t exist at the time. <\/p>\n

In 2024, a jury ruled that<\/a> Masimo\u2019s W1 and Freedom watches \u201cwillfully violated Apple\u2019s patent rights in smartwatch designs.\u201d The W1 is no longer sold to consumers. <\/p>\n

\u201cThrough its parallel district court litigation and the present petition, Masimo seeks to pressure the Commission to exceed its statutory authority and prevent millions of Americans from accessing Apple\u2019s redesigned Blood Oxygen feature,\u201d Apple says in its latest filing in the ITC case. \u201cMasimo has no meaningful domestic industry product that would benefit from this exclusion\u2014its asserted domestic industry product, the Masimo W1, has still not been sold in more than de minimis quantities even two years after the conclusion of the underlying Investigation, and Masimo no longer sells any version of the Masimo W1 to consumers.\u201d <\/p>\n

\u201cMasimo\u2019s latest filings only reinforce that Masimo has been abusing the powers of the Commission by seeking to exclude important consumer products to \u2018protect\u2019 a nonexistent domestic industry,\u201d Apple continues. <\/p>\n

The ITC says it expects to make a decision within six months.<\/p>\n

My favorite iPhone accessories:<\/p>\n

Follow Chance:\u00a0Threads<\/a>,\u00a0Bluesky<\/a>,\u00a0Instagram<\/a>, and\u00a0Mastodon<\/a>.\u00a0<\/p>\n

\t\t\t\t
\n\t\t\t\"Add
\n\t\t\t\"Add
\n\t\t<\/a><\/p>\n

FTC: We use income earning auto affiliate links. More.<\/a><\/p>\n

\"\"<\/a>\t\t\t\t